Silvane F. Murta
Belo Horizonte, MG, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 88 publications
Essential role of glycogen synthase kinase 3 in regulating growth, drug response, and infectivity in Leishmania infantum.
Journal: Antimicrobial agents and chemotherapy
Published: July 06, 2026
Glycosomal ABC transporter 3 (GAT3) is associated with antileishmanial drug susceptibility in Leishmania infantum.
Journal: Parasitology international
Published: June 04, 2026
Discovery of an efficacious 2-ethyl-4-phenylthiazole derivative against acute Chagas disease via multiparametric hit-to-lead optimization and in vivo efficacy.
Journal: European journal of medicinal chemistry
Published: March 09, 2026
5,6,7,8-Tetrahydroimidazo[1,2-a]pyrazine-based thiosemicarbazones as anti-Trypanosoma cruzi agents.
Journal: Bioorganic & medicinal chemistry
Published: January 24, 2026
The atypical dual-specificity protein phosphatase (DUSP)/kinatase of Leishmania infantum modulates infectivity, oxidative stress response and antimonial resistance.
Journal: PLoS neglected tropical diseases
Published: November 10, 2025
Advances and challenges in the search for new treatments for Chagas disease.
Journal: Memorias do Instituto Oswaldo Cruz
Published: October 23, 2025
Biological and molecular characterisation of in vitro selected miltefosine-resistant Leishmania amazonensis lines.
Journal: International journal for parasitology. Drugs and drug resistance
Published: June 20, 2025
Easy Obtainment and Biological Applicability of Pinocarvyl Acetate by Encapsulating of the Microlicia graveolens Essential Oil in Oil-in-Water Nanoemulsions.
Journal: Pharmaceutics
Published: June 16, 2025
Glycosomal ABC transporter 3 (GAT3) deletion enhances the oxidative stress responses and reduces the infectivity of Trypanosoma cruzi.
Journal: PLoS neglected tropical diseases
Published: May 24, 2025
Hit-to-Lead Studies of Pyrazinylpiperazines against Visceral Leishmaniasis: Pharmacokinetic Profile and In Vivo Efficacy of Potent Compounds against Leishmania infantum.
Journal: ACS pharmacology & translational science
Published: April 29, 2025
Last Updated: 09/26/2026